129 related articles for article (PubMed ID: 18765549)
1. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma.
Raz DJ; Ray MR; Kim JY; He B; Taron M; Skrzypski M; Segal M; Gandara DR; Rosell R; Jablons DM
Clin Cancer Res; 2008 Sep; 14(17):5565-70. PubMed ID: 18765549
[TBL] [Abstract][Full Text] [Related]
2. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
3. Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
Yamashita S; Chujo M; Tokuishi K; Anami K; Miyawaki M; Yamamoto S; Kawahara K
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1303-8. PubMed ID: 19818968
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
5. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
6. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.
Endoh H; Tomida S; Yatabe Y; Konishi H; Osada H; Tajima K; Kuwano H; Takahashi T; Mitsudomi T
J Clin Oncol; 2004 Mar; 22(5):811-9. PubMed ID: 14990636
[TBL] [Abstract][Full Text] [Related]
7. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
[TBL] [Abstract][Full Text] [Related]
8. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
[TBL] [Abstract][Full Text] [Related]
11. High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma.
Anagnostou VK; Bepler G; Syrigos KN; Tanoue L; Gettinger S; Homer RJ; Boffa D; Detterbeck F; Rimm DL
Clin Cancer Res; 2009 Jun; 15(12):4157-64. PubMed ID: 19509151
[TBL] [Abstract][Full Text] [Related]
12. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
[TBL] [Abstract][Full Text] [Related]
13. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
15. Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma.
Guo L; Ma Y; Ward R; Castranova V; Shi X; Qian Y
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3344-54. PubMed ID: 16740756
[TBL] [Abstract][Full Text] [Related]
16. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
17. Three-gene prognostic classifier for early-stage non small-cell lung cancer.
Lau SK; Boutros PC; Pintilie M; Blackhall FH; Zhu CQ; Strumpf D; Johnston MR; Darling G; Keshavjee S; Waddell TK; Liu N; Lau D; Penn LZ; Shepherd FA; Jurisica I; Der SD; Tsao MS
J Clin Oncol; 2007 Dec; 25(35):5562-9. PubMed ID: 18065728
[TBL] [Abstract][Full Text] [Related]
18. TNM stage is the most important determinant of survival in metachronous lung cancer.
Lee BE; Port JL; Stiles BM; Saunders J; Paul S; Lee PC; Altorki N
Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS; Choi JE; Lee WK; Choi YY; Kam S; Kim MJ; Jeon HS; Lee EB; Kim DS; Lee MH; Kim IS; Jheon S; Park JY
J Clin Oncol; 2009 Dec; 27(34):5823-9. PubMed ID: 19826114
[TBL] [Abstract][Full Text] [Related]
20. Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung.
Ikeda J; Oda T; Inoue M; Uekita T; Sakai R; Okumura M; Aozasa K; Morii E
Cancer Sci; 2009 Mar; 100(3):429-33. PubMed ID: 19077003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
